Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/27/2003CN1439017A Novel compounds
08/27/2003CN1438479A Technology for sorting and extracting matter in liquid cell using laser
08/27/2003CN1438314A Bone morphogenesis protein-2 gene modified tissue engineered bone construction
08/27/2003CN1438313A Method for preparing microcapsulized functional cell
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/27/2003CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof
08/26/2003US6610909 Method for the commercial production of transgenic plants
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610843 Modified starch from plants, plants synthesizing the same, as well as process for their production
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610764 Polyhydroxyalkanoate compositions having controlled degradation rates
08/26/2003US6610668 Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
08/26/2003US6610656 Activating osteogenesis using hedgehog genes or proteins coded by hybridized nucleic acids
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610544 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid
08/26/2003US6610543 Cellular culture medium, particularly for in vitro fertilization, or for the culture of follicles, male germ cells or embryos
08/26/2003US6610542 Human immunodeficiency virus; incubating umbilical cord blood cells in a growth medium containing mezerin and concanavalin A; culturing while maintaining reduced levels of the virus; gene expression inhibition
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610540 Low oxygen culturing of central nervous system progenitor cells
08/26/2003US6610538 Selecting limbar stem cells capable of regenerating corneal tissue in vitro, preparing a fibrin substrate able to allow limbar cells to grow for production of laminae of epithelium corneae; preparing limbar cornea cell cultures in vitro
08/26/2003US6610536 Nucleic acids and polypeptides
08/26/2003US6610535 Progenitor cells and methods and uses related thereto
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610516 A glycoprotein is produced by a process comprising culturing mammalian host cells expressing nucleic acid encoding a glycoprotein in the presence of (a) a factor that modifies growth state in a cell culture, (b) a divalent metal cation or
08/26/2003US6610513 Receptor proteins
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610507 Polynucleotides encoding patched proteins
08/26/2003US6610502 2-amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid; to a method for testing a biological function by quantitating 2- amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid in a collected
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610476 Nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant,DNA methods and production of viral RNA are disclosed. Such polypeptides can
08/26/2003US6610474 Cells for detection of influenza and parainfluenza viruses
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610302 Peptides for the treatment and amelioration of tumor-producing diseases, and methods for their utilization.
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/26/2003US6610288 Isolated populations of such hepatocytes and methods for using the hepatocytes to treat subjects with disorders characterized by insufficient liver function are described. The porcine hepatocytes can be either hepatocytes isolated
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003069339A1 Method for generating recombinant human platelets for identifying therapeutic target proteins
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068961A2 Method to modify differentiation of pluripotential stem cells
08/21/2003WO2003068960A1 Transposon being functional in mammals
08/21/2003WO2003068957A1 METHOD OF SCREENING INK4 FAMILY GENE EXPRESSION CONTROLLER AND p19 GENE PROMOTER
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068955A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
08/21/2003WO2003068952A1 Stat3 activated stem cell
08/21/2003WO2003068938A2 Human fetal bladder-derived epithelial cells
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068931A2 Purification of the leading front migratory cells
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068917A2 Functionalization of carotenoid compounds
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068911A2 Citrus tristeza virus resistance genes and methods of use
08/21/2003WO2003068906A1 Systems and methods for rapidly changing the solution environment around sensors
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068802A2 Materials and methods for preparing dimeric growth factors
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068357A2 Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
08/21/2003WO2003068287A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
08/21/2003WO2003068248A1 Cell delivery system
08/21/2003WO2003068172A2 Undesignated allogeneic stem cell bank
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003068149A2 Preparations of nucleus pulposus cells and methods for their generation, identification, and use
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003045304A3 Mutable vaccines
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003027300A3 Use of aminoglycoside resistance gene
08/21/2003WO2003027245B1 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
08/21/2003WO2003024471A3 Effect of growth hormone and igf-1 on neural stem cells and therapeutic application
08/21/2003WO2003024404A3 Chemokines as adjuvants of immune response
08/21/2003WO2003018760A3 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003002609A3 Dual-specific ligand and its use
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002086125A3 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002077210A3 Methods to culture circovirus
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
1 ... 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 ... 1827